Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules
- PMID: 29566402
- DOI: 10.1055/a-0588-4885
Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules
Abstract
Background: Ultrasound guided fine needle aspiration biopsy with cytologic analysis is an initial step in diagnostic of thyroid nodules. Unfortunately, up to 30% of biopsies are indeterminate and diagnostic surgery is required. The aim of this study was to estimate the diagnostic value of BRAF V600E mutation status combined with cytomorphological features for diagnosis of papillary thyroid cancer (PTC) in cytologically indeterminate thyroid nodules.
Methods: A prospective study analyzed patients who had ultrasound suspicious thyroid nodules, underwent fine needle aspiration and cytological examination, and were classified according to the Bethesda system. Patients from indeterminate diagnostic categories were examined for BRAF V600E mutation and 22 cytomorphological features, and underwent thyroid surgery. A binary logistic regression model was used to evaluate the diagnostic utility.
Results: A total of 219 patients met study criteria. After histological examination, 77 (35.2%) patients were diagnosed with PTC and 142 (64.8%) with benign nodular thyroid disease. According to logistic regression model, significant features for PTC diagnosis were: liquid colloid consistency, papillary structures, eosinophilic colloid bodies, and BRAF V600E mutation. Risk groups classified by this model have sensitivity of 80.5% (95% CI: 69.9 to 88.7), specificity of 99.3% (95% CI: 96.1 to 100), positive predictive value of 98.4% (95% CI: 89.8 to 99.8), negative predictive value of 90.4% (95% CI: 85.7 to 93.7), and accuracy of 92.7% (95% CI: 88.4 to 95.8) for PTC diagnosis.
Conclusions: Evaluation of BRAF V600E mutation status combined with cytomorphological features for diagnosis of PTC in cytologically indeterminate thyroid nodules can significantly improve diagnostic accuracy and reduce the number of diagnostic operations (calculator available at www.ptc-calc.we2host.lt).
© Georg Thieme Verlag KG Stuttgart · New York.
Conflict of interest statement
No conflict of interest has been declared by the authors.
Similar articles
-
High BRAFV600E mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules.Medicine (Baltimore). 2019 Jul;98(28):e16343. doi: 10.1097/MD.0000000000016343. Medicine (Baltimore). 2019. PMID: 31305422 Free PMC article.
-
The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?Am Surg. 2024 Dec;90(12):3209-3215. doi: 10.1177/00031348241265143. Epub 2024 Jul 24. Am Surg. 2024. PMID: 39047144
-
Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.Pathol Res Pract. 2020 Aug;216(8):153037. doi: 10.1016/j.prp.2020.153037. Epub 2020 May 30. Pathol Res Pract. 2020. PMID: 32703500
-
BRAFV600E mutation as a predictor of thyroid malignancy in indeterminate nodules: A systematic review and meta-analysis.Eur J Surg Oncol. 2017 Jul;43(7):1219-1227. doi: 10.1016/j.ejso.2016.11.003. Epub 2016 Nov 22. Eur J Surg Oncol. 2017. PMID: 27923591
-
Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis.Hum Pathol. 2015 Oct;46(10):1443-54. doi: 10.1016/j.humpath.2015.06.001. Epub 2015 Jun 16. Hum Pathol. 2015. PMID: 26232865
Cited by
-
Comparative efficiency of differential diagnostic methods for the identification of BRAF V600E gene mutation in papillary thyroid cancer (Review).Exp Ther Med. 2024 Feb 20;27(4):149. doi: 10.3892/etm.2024.12437. eCollection 2024 Apr. Exp Ther Med. 2024. PMID: 38476918 Free PMC article. Review.
-
Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAFV600E mutation in papillary thyroid carcinoma.J Clin Lab Anal. 2019 Jul;33(6):e22902. doi: 10.1002/jcla.22902. Epub 2019 Apr 25. J Clin Lab Anal. 2019. PMID: 31021028 Free PMC article.
-
The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer.J Cancer. 2020 Jan 1;11(4):932-939. doi: 10.7150/jca.33105. eCollection 2020. J Cancer. 2020. PMID: 31949496 Free PMC article.
-
High BRAFV600E mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules.Medicine (Baltimore). 2019 Jul;98(28):e16343. doi: 10.1097/MD.0000000000016343. Medicine (Baltimore). 2019. PMID: 31305422 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous